Convalescent plasma in COVID-19. Mortality-safety first results of the Prospective Multicenter FALP 001-2020 trial
…, A Aguirre, R González-Steigmaier… - medRxiv, 2020 - medrxiv.org
Background The use of convalescent plasma (CP) to treat COVID-19 has shown promising
results; however, its effectiveness remains uncertain. The purpose of this study was to …
results; however, its effectiveness remains uncertain. The purpose of this study was to …
Convalescent Plasma in COVID-19. Mortality-Safety First Results of the Prospective Multicenter FALP 001-2020 Trial
…, A Aguirre, R Gonzalez-Steigmaier… - 2020 - pesquisa.bvsalud.org
BackgroundThe use of convalescent plasma (CP) to treat COVID-19 has shown promising
results; however, its effectiveness remains uncertain. The purpose of this study was to …
results; however, its effectiveness remains uncertain. The purpose of this study was to …
Convalescent Plasma in COVID-19. Mortality-Safety First Results of the Prospective Multicenter FALP 001-2020 Trial (preprint)
…, A Aguirre, R Gonzalez-Steigmaier… - 2020 - pesquisa.bvsalud.org
BackgroundThe use of convalescent plasma (CP) to treat COVID-19 has shown promising
results; however, its effectiveness remains uncertain. The purpose of this study was to …
results; however, its effectiveness remains uncertain. The purpose of this study was to …